MB, Levis & Associates’s Comerica CMA Stock Holding History

MB, Levis & Associates’s Portfolio CMA Stock Details CMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	-$5.58K	–	284
2023 Q4	$5.58K	Buy	+100	New	+$4.52K	﹤0.01%	208

Other funds holding CMA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MB, Levis & Associates's CMA Position: Q1 2024 in Review

MB, Levis & Associates sold out of Comerica (CMA) in Q1 2024, closing a stake of 100 shares — an estimated $5.58K sold.

MB, Levis & Associates first reported a position in CMA in Q4 2023 and held it in 1 quarter. The position peaked at $5.58K in Q4 2023. 558 funds tracked by Wall St. Rank hold CMA as of Q1 2024.

MB, Levis & Associates reported no remaining Comerica position as of Q1 2024 after selling out during the quarter.
MB, Levis & Associates sold 100 Comerica shares in Q1 2024, an estimated $5.58K.
MB, Levis & Associates first reported a position in Comerica in Q4 2023 and held it in 1 quarter.
MB, Levis & Associates's Comerica position peaked at $5.58K in Q4 2023.
558 funds tracked by Wall St. Rank held Comerica as of Q1 2024.

Based on MB, Levis & Associates's 13F filing for Q1 2024, filed 7 May 2025.